This article is all about what’s new and what it might mean for us, covering the latest in genetics in news. New methods like ...

Revvity targets 2026 growth with multiomics, AI-powered base editing, NGS newborn screening, and immunotherapy advances.

In a wide-ranging discussion on the future of genomics and cancer diagnostics in India, senior leaders from Strand Life ...

Lab Thread Ltd, a UK-based life science software company, today announced the beta launch of its flagship unified lab ...

An investigation into cellular components in bacteria has unexpectedly uncovered a feature with relevance across many life ...

Even as they develop at their primary site, pancreatic cancer cells are already expressing the genes that will determine ...

Dallas-based Meros Investment Management purchased 159,945 shares of Azenta valued at $4.6 million in the third quarter. The position represents 2% of Meros’s 13F reportable assets under management.

A virus carried by 95% of adults from childhood may trigger bladder cancer decades later by damaging cells during immune ...

Syntax Bio, a synthetic biology company programming the next generation of cell therapies, today announced the publication of ...

Xu, W. , Xing, X. and Cheng, S. (2025) Urine-Based Liquid Biopsy for Detecting Recurrence of Bladder Cancer. International ...